Vol. 3 No. 1 (2023): Injuries, Causes, & Treatments

Articles

• The Canaries in the Human DNA Mine

  Julian Gillespie

  929-956

  • PDF

• Assessment of Comirnaty Injections of Pregnant Women in the Manufacturer’s Risk Management Plan and by the European Medicines Agency: Mandatory Injections for Caregivers in France

  Jérôme Sainton

  911-928

  • PDF

• Safety of mRNA Vaccines Administered During the First Twenty-Four Months of the International COVID-19 Vaccination Program

  Eliana Romero, Shawn Fry, Brian Hooker

  891-910

  • PDF

• Abnormal Clots and All-Cause Mortality During the Pandemic Experiment: Five Doses of COVID-19 Vaccine Are Evidently Lethal to Nearly All Medicare Participants

  Daniel Santiago, John W Oller

  847-890

  • PDF

• Supplementary Files for Santiago & Oller Source Data for Statistical Analyses

  John Oller; CDC and Medicare US and Connecticut

• Laboratory testing for COVID-19

  Emergency Response Technical Centre NIVD under China CDC

  846.1-846.57

  • PDF

• Response to Comments on Kämmerer, et al. (2023) regarding RT-PCR Testing

  Ulrike Kämmerer, Sona Pekova, Rainer J. Klement, Rogier Louwen, Pieter Borger, Klaus Steger

  846.5-846.9

  • PDF

• Comments on Kämmerer, et al. (2023) regarding RT-PCR Testing

  Fabio Franchi, Jerneja Tomsic

  846.1-846.4

  • PDF

• RT-PCR Test Targeting the Conserved 5'-UTR of SARS-CoV-2 Overcomes Shortcomings of the First WHO-Recommended RT-PCR Test

  Ulrike Kämmerer, Sona Pekova, Rainer Klement, Rogier Louwen, Pieter Borger, Klaus Steger

  818-846

  • PDF

• Chemical-physical criticality and toxicological potential of lipid nanomaterials contained in a COVID-19 mRNA vaccine

  Gabriele Segalla

  787-817

  • PDF

• A 6-Week Time Period May not be Sufficient to Identify Potential Adverse Events Following COVID-19 Vaccination

  Hélène Banoun, Patrick Provost

  771-812

  • PDF

• Emergence of a New Creutzfeldt-Jakob Disease: 26 Cases of the Human Version of Mad-Cow Disease, Days After a COVID-19 Injection

  Jean-Claude Perez, Claire Moret-Chalmin, Luc Montagnier

  727-770

  • PDF

• The Blind Spot in COVID-19 Vaccination Policies: Under-Reported Adverse Events

  Patrick Provost

  707-726

  • PDF

• Injuries, Causes, & Treatments, IJVTPR 3(1): For “Such a Time as This”

  John W. Oller

  687-706

  • PDF